For large mines, there is an iron rule in the selection and use of beneficiation agents: stability is paramount.

Why is stability so important? Because the size of large mines is too large. Any small fluctuations can be amplified into serious problems by huge processing volumes. The effectiveness of the medicine has decreased by half today, and tomorrow the loss may be the profit of a car.

Today, we will talk about the special requirements of large-scale mines for mineral processing reagents from the perspective of "stability".

The ore is unstable, and medication is needed to replenish it

Large mines often need to simultaneously mine multiple mining areas, or even multiple mines. The ores in each mining area are different - some are soft, some are hard, some have high sulfur content, and some have high mud content.

This brings a trouble: the properties of the ore entering the factory are constantly changing. If the reagent scheme remains unchanged, the flotation index will fluctuate like riding a roller coaster.

What should I do? There are two ways.

One is passive adaptation - waiting for the indicators to deteriorate before finding the cause and adjusting the medication. The disadvantage of this approach is slow response, and by the time the problem is discovered, the loss has already been incurred.

Another approach is proactive prediction - establishing a database of ore properties, conducting preliminary research on ores from different mining areas, and developing several backup plans. The reagent formula shall be adjusted in advance according to the source of incoming ore on the day. This approach requires a significant upfront investment, but once established, it can keep fluctuations within a very small range.

The reason why large mines are willing to invest in this area is because they calculate that every penny spent on forecasting can be saved from reduced losses.

Different batches of drugs should have the same effect

The core requirement for pharmaceutical suppliers in large mines is often not "the best effect", but "batch stability".

What does that mean? This batch of goods should be the same as the next one. The composition, purity, and performance must be highly consistent.

Why is this requirement so high? Because the production of large mines operates continuously, it is not possible to stop the machine for testing at will. If the previous batch of drugs had good effects and this batch of drugs had poor effects, it will be difficult for operators to determine where the problem lies - whether the ore has changed or the drugs have changed? It may take a long time to investigate, and during this time, losses continue to occur.

So, when selecting suppliers, large mines will carefully examine their quality control systems. Does the supplier have a standardized production process? Is a full inspection conducted on each batch of products before leaving the factory? Can the inspection report be provided with the goods? These details directly determine whether one can enter the supplier list of large mines.

Manufacturers who can control product indicators within a narrow range are more likely to win the favor of large mines even if their prices are slightly higher. Because on the ledger of large mines, 'stability' has a price - they are willing to pay a premium for stability.

The 'side effects' of drugs should be controllable

Any medication has "side effects" - besides what it wants to do, it can also do things it doesn't want to do.

For example, lime can adjust the slurry to a suitable alkalinity, but it also inhibits pyrite. In most gold mines, suppressing pyrite is a good thing because we don't want pyrite to float up with the gold. But in some gold mines, gold is actually encapsulated in pyrite - inhibiting pyrite is equivalent to inhibiting gold as well. At this point, lime becomes a 'helper'.

For example, water glass can inhibit vein minerals such as quartz and is a good inhibitor. But it will also change the ion environment of the slurry, affecting the effectiveness of other agents. Adding too much may actually have a counterproductive effect.

Engineers in large mines are well versed in the "side effects" of each type of medication. When designing medication plans, they not only need to consider the "main effect", but also anticipate the "side effects" and think of countermeasures in advance. Sometimes, one may even intentionally exploit the "side effects" of a certain medication to achieve specific goals. The ability to finely regulate is the core manifestation of large-scale mining beneficiation technology.

Smooth switching of environmentally friendly chemicals

In recent years, more and more traditional sodium cyanide has been replaced by environmentally friendly beneficiation agents. But for large mines, 'dressing up' is not an easy task.

The production line of large mines operates around the clock and cannot be shut down due to dressing changes. Moreover, the technology of large mines has been in operation for many years, and the operators are well aware of the "temperament" of the original reagents. Changing to a new medication means starting from scratch and adapting again.

So, when choosing environmentally friendly chemicals, large mines attach great importance to "compatibility" - can they be directly replaced without changing existing equipment and processes? Operators do not need to learn new operating methods, they only need to fine tune some parameters?

Environmental protection agents that prioritize "compatibility" as a core indicator from the beginning of their design have the least resistance in the promotion process in large mines. They enable large mines to smoothly complete green transformation without the risk and cost of production shutdown and renovation.

Supplier's' service radius'

Large mines are distributed throughout the country, some even overseas. The service capability of pharmaceutical suppliers largely depends on the "service radius" - how far is it from the mine? Can we arrive at the scene in a short time?

Problems in mines often come suddenly. The sudden decline in flotation indicators may be due to changes in the ore, problems with the reagents, or equipment malfunctions. At this point, the quickest way is for the supplier's engineers to rush to the site with testing equipment and spare chemicals, and work with the mine engineers to investigate the cause.

If the supplier is thousands of miles away and it takes several days to send someone over, then the losses during these days can only be borne by oneself. Therefore, when selecting suppliers, large mines will give priority to manufacturers who have service outlets around the mine and can respond quickly. Some large mines even require suppliers to have technical personnel stationed in the mining area to provide support at any time.

The 'safe water level' of pharmaceutical inventory

Large mines must maintain a certain inventory of chemicals to cope with the risk of supply chain disruptions. But the larger the inventory, the better - having too much inventory can take up funds, occupy warehouses, and pose a risk of spoilage; There is too little inventory, and if the supplier runs out of supply, the production line will have to stop.

Determining the 'safe water level' is a discipline. Consider various factors such as the supplier's production cycle, transportation time, historical on-time delivery rate, and the switching time of alternative suppliers. Experienced large mines will set different safety stock standards for each major chemical and regularly evaluate and adjust them.

Some large mines also adopt a strategy of "main supplier+alternative supplier". The main supplier supplies the majority of the goods, while alternative suppliers maintain a small inventory and occasionally purchase some to maintain a cooperative relationship. In this way, once there is a problem with the main supplier, it can quickly switch to alternative suppliers without affecting production.

From "Cost Center" to "Technical Core"

In the past, in many mining enterprises, the procurement of mineral processing agents was seen as a pure "cost center" - buying cheap is good procurement. Now, this concept is changing.

More and more large mines are realizing that beneficiation reagents are not ordinary consumables, but key variables that determine beneficiation indicators. Saving money on pharmaceuticals may result in losing a lot of money on recovery rates. Instead of bargaining based on the unit price of drugs, it is better to focus on optimizing the drug scheme - using more suitable drug combinations, more precise addition control, increasing recovery rates, and reducing consumption.

The result of this shift in thinking is that large mines have begun to elevate pharmaceutical management to a "technical core" work, no longer solely responsible by the procurement department, but deeply involved by mineral processing engineers. The selection of pharmaceutical suppliers is no longer based on who offers the lowest price, but on whose technical solutions are the best and service capabilities are the strongest.

This is a microcosm of large-scale mines moving towards refined management. In today's increasingly scarce resources and fierce competition, whoever can win in details will be able to establish a firm foothold in the market.